Pharmafile Logo
Pharmafocus logo
Advanced Search

R&D productivity

Showing 4 posts of 4 posts found.

Value destruction: pharma has only itself to blame

February 10, 2012
R&D productivity

Pharma has only itself to blame for destroying value from its R&D pipeline, according to Andrew Baum, managing director of …

News
k_frazier_landscape_web

Frazier defends R&D investment and attacks price pressure

December 14, 2011
Research and Development, Sales and Marketing Merck, R&D productivity, prices

Merck & Co chief executive Kenneth Frazier has expressed concern that European governments increasingly want to pay unrealistically low prices …

News
lamattinalee

Big pharma: big rewards come from big risks

December 5, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, R&D productivity

John LaMattina joined Pfizer in 1977 after having completed his PhD in organic chemistry, and moved up through the ranks …

Feature

Big pharma counts cost of R&D decline

November 23, 2011
Research and Development Deloitte, GSK, IIR, R&D productivity

Leading pharma firms are getting around 30% less on their investments in research and development compared to last year, according …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025